نتایج جستجو برای: factor ii g20210a mutation

تعداد نتایج: 1608670  

Journal: :Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2005
Sirish I Kumar Ashish Kumar Srikant Srivastava Vivek A Saraswat Rakesh Aggarwal

BACKGROUND Factor V Leiden (FVL) and prothrombin gene (G20210A) mutations are known to be associated with venous thromboembolism. Several studies have shown an association of these mutations with hepatic venous outflow tract obstruction (HVOTO). We studied the prevalence of these mutations among patients with HVOTO in northern India in comparison with healthy population. METHODS Genomic DNA f...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 1999
O Salomon D M Steinberg A Zivelin S Gitel R Dardik N Rosenberg S Berliner A Inbal A Many A Lubetsky D Varon U Martinowitz U Seligsohn

The inherited thrombophilias--deficiencies of protein C, protein S, and antithrombin III--and the prothrombotic polymorphisms factor V G1691A and factor II G20210A predispose patients toward venous thromboembolism (VTE). The aim of this study was to determine the prevalence of single and combined prothrombotic factors in patients with idiopathic VTE and to estimate the associated risks. The stu...

Journal: :Blood 2000
J M Soria L Almasy J C Souto I Tirado M Borell J Mateo S Slifer W Stone J Blangero J Fontcuberta

Association studies suggest that the G20210A mutation (G to A substitution at nucleotide position 20210) in the prothrombin gene (PT) is associated with increased plasma prothrombin activity and with increased risk for venous thromboembolism. To test directly for linkage between this PT variant and plasma prothrombin activity we performed a family-based study. The G20210A genotypes and plasma p...

2014
Guttula Satyavani

The study here is to estimate the frequency of Prothrombin allelic polymorphisms from randomly selected general population. Prothrombin is a blood-clotting protein, a vitamin K-dependent clotting factor. The gene has a mutation at position 20210, hence the disorder being referred to as Prothrombin mutation 20210. The PT20210 polymorphisms were identified using simple PCR and followed by Restric...

2007
Karin Kurnik Wolfhart Kreuz Sylvia Horneff Christine Düring Rosemarie Schobess Christoph Bidlingmaier Carmen Escuriola Ettingshausen Anne Krümpel Nadia Bogdanova Ulrike Nowak-Göttl

Hemophilia A (HA) is an X-linked genetic hemorrhagic disorder resulting from a deficiency of blood coagulation factor VIII. The mutation type within the factor VIII gene may influence the clinical severity of hemophilia. It has also recently been suggested that the clinical phenotype of HA is influenced by co-inheritance of the factor V G1691A mutation or the factor II G20210A variant. This cli...

Journal: :Clinical chemistry and laboratory medicine 2005
Christoph L Klein János Márki-Zay Philippe Corbisier David Gancberg Susan Cooper Donato Gemmati Walter-Michael Halbmayer Steve Kitchen Béla Melegh Michael Neumaier Johannes Oldenburg Elisabeth Oppliger Leibundgut Pieter H Reitsma Sandra Rieger Heinz G Schimmel Michael Spannagl Attilia Tordai Alberto Tosetto Sophie Visvikis Renata Zadro Christine Mannhalter

The Scientific Committee of Molecular Biology Techniques (C-MBT) in Clinical Chemistry of the IFCC has initiated a joint project in co-operation with the European Commission, Joint Research Centre, Institute of Reference Materials and Measurements to develop and produce plasmid-type reference materials (RMs) for the analysis of the human prothrombin gene G20210A mutation. Although DNA tests hav...

Journal: :Clinical chemistry 2001
M J Hessner K D Friedman K V Voelkerding S Huber D Ryan B Nuccie M Ledford

References 1. Sunderman FW. The clinical biochemistry of 59-nucleotidase [Review]. Ann Clin Lab Sci 1990;20:123–39. 2. Bodansky O, Schwartz MK. 59-Nucleotidase [Review]. Adv Clin Chem 1968; 11:277–328. 3. Dixon TF, Purdom M. Serum 59-nucleotidase. J Clin Pathol 1954;7:341–3. 4. Eshchar J, Rudzki C, Zimmerman HJ. Serum levels of 59-nucleotidase in disease. Am J Clin Pathol 1967;47:598–606. 5. Be...

Journal: :European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2015
F Vazquez M Rodger M Carrier G Le Gal J-L Reny F Sofi T Mueller S Nagpal P Jetty E Gandara

OBJECTIVE/BACKGROUND Despite being an important risk factor for venous thromboembolism, the role of the prothrombin G20210A mutation in patients with arterial disease remains unclear. The aim of this review was to evaluate the association of prothrombin G20210A and lower extremity peripheral arterial disease (PAD). METHODS This was a systematic review and meta-analysis of case-control studies...

Journal: :Hemoglobin 2004
Fábio David Couto Wendell Vilas Boas Isa Lyra Angela Zanette Marie France Dupuit Mari Ney Tavares Almeida Mitermayer Galvão Reis Marilda Souza Gonçalves

The C677T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and the G20210A mutation at the 3' untranslated region (3'UTR) of the prothrombin gene may be considered to be genetic risk factors that contribute to the clinical heterogeneity in sickle cell disease. The current study investigated a group of sickle cell (SS) patients from Salvador-Bahia, Northeast Brazil in order to deter...

Journal: :Clinical science 2003
Masatoshi Hayashi

Schlembach and co-workers in this issue of Clinical Science have studied the association of maternal and/or fetal factor V Leiden (FVL) and prothrombin G20210A gene mutation with HELLP syndrome and intrauterine growth restriction (IUGR) to confirm whether these genetic mutations are important risk factors for the pathogenesis of the HELLP syndrome, leading to an inadequate maternal-fetal circul...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید